Ambea AB (publ) (STO:AMBEA)
Sweden · Delayed Price · Currency is SEK 128.70
-1.50 (-1.15%)
Oct 31, 2025, 12:59 PM CET
Ambea AB Revenue
Ambea AB had revenue of 4.09B SEK in the quarter ending June 30, 2025, with 16.17% growth. This brings the company's revenue in the last twelve months to 15.05B, up 7.29% year-over-year. In the year 2024, Ambea AB had annual revenue of 14.32B with 5.53% growth.
Revenue (ttm)
15.05B
Revenue Growth
+7.29%
P/S Ratio
0.70
Revenue / Employee
895.19K
Employees
37,864
Market Cap
10.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.32B | 751.00M | 5.53% |
| Dec 31, 2023 | 13.57B | 934.00M | 7.39% |
| Dec 31, 2022 | 12.64B | 1.16B | 10.08% |
| Dec 31, 2021 | 11.48B | 395.00M | 3.56% |
| Dec 31, 2020 | 11.08B | 43.00M | 0.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |
Ambea AB News
- 1 year ago - Ambea AB (FRA:6MA) Q2 2024 Earnings Call Transcript Highlights: Strong EBITDA Growth and ... - GuruFocus
- 1 year ago - Q2 2024 Ambea AB (publ) Earnings Call Transcript - GuruFocus